Cargando…
Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer
BACKGROUND: Venous thromboembolism (VTE) following breast cancer chemotherapy is common. Chemotherapy-induced alterations in markers of haemostasis occur during chemotherapy. In this study we investigated the changes in serum and plasma VEGF, together with platelet release of VEGF and related these...
Autores principales: | Kirwan, Cliona C, Byrne, Gerard J, Kumar, Shant, McDowell, Garry |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794853/ https://www.ncbi.nlm.nih.gov/pubmed/20016693 http://dx.doi.org/10.1186/2040-2384-1-7 |
Ejemplares similares
-
Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.
por: Banks, R. E., et al.
Publicado: (1998) -
Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer
por: Kirwan, C C, et al.
Publicado: (2008) -
The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016) -
Expression of vascular endothelial growth factor (VEGF) in equine sarcoid
por: Martano, Manuela, et al.
Publicado: (2018) -
VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
por: Barratt, Shaney L., et al.
Publicado: (2018)